Literature DB >> 16222938

Trends in melanoma mortality in Australia: 1950-2002 and their implications for melanoma control.

Peter Baade1, Michael Coory.   

Abstract

OBJECTIVE: To assess whether the stabilisation in melanoma mortality rates observed from 1985 to 1994 has progressed to a statistically significant decrease.
METHOD: Joinpoint trends analyses of Australian melanoma mortality data between 1950 and 2002, stratified by age.
RESULTS: The latest data showed statistically significant decreases in mortality rates for both men and women younger than 55 years (percentage change per year, men 35-55 years: -2.4%; 95% CI -3.5% -- -1.3%; women: -2.9%; 95% CI -4.7%-- -1.1%). For ages 55-79 years, rates are now stable for both men (+0.3%; 95% CI -0.6%-- +1.1%) and women (-0.5%; 95% CI -1.4%-- +0.4%), whereas previously the rates were increasing. For both men and women 80 years or older, rates have continued their statistically significant increase of 3-4% per year. CONCLUSIONS AND IMPLICATIONS: Since no similar reductions in incidence have been reported, the most likely cause of the recent statistically significant decreases in mortality is early detection. Although it may be too early to be seeing the full benefits of primary prevention programs that started in the 1980s, they have the potential to lead to large reductions in mortality in the future.

Entities:  

Mesh:

Year:  2005        PMID: 16222938     DOI: 10.1111/j.1467-842x.2005.tb00211.x

Source DB:  PubMed          Journal:  Aust N Z J Public Health        ISSN: 1326-0200            Impact factor:   2.939


  16 in total

1.  Cure of cutaneous melanoma.

Authors:  J Meirion Thomas; Victoria Giblin
Journal:  BMJ       Date:  2006-04-29

Review 2.  Growth factors and oncogenes as targets in melanoma: lost in translation?

Authors:  Lawrence Kwong; Lynda Chin; Stephan N Wagner
Journal:  Adv Dermatol       Date:  2007

3.  Unexpected high response rate to traditional therapy after dendritic cell-based vaccine in advanced melanoma: update of clinical outcome and subgroup analysis.

Authors:  Laura Ridolfi; Massimiliano Petrini; Laura Fiammenghi; Anna Maria Granato; Valentina Ancarani; Elena Pancisi; Emanuela Scarpi; Massimo Guidoboni; Giuseppe Migliori; Stefano Sanna; Francesca Tauceri; Giorgio Maria Verdecchia; Angela Riccobon; Linda Valmorri; Ruggero Ridolfi
Journal:  Clin Dev Immunol       Date:  2010-09-27

4.  Prevention of malignant melanoma.

Authors:  G Chaidemenos; A Stratigos; M Papakonstantinou; F Tsatsou
Journal:  Hippokratia       Date:  2008-01       Impact factor: 0.471

Review 5.  Melanoma epidemiology and public health.

Authors:  Marianne Berwick; Esther Erdei; Jennifer Hay
Journal:  Dermatol Clin       Date:  2009-04       Impact factor: 3.478

6.  Incidence and mortality trends of melanoma in Croatia.

Authors:  Jelena Barbarić; Ariana Znaor
Journal:  Croat Med J       Date:  2012-04       Impact factor: 1.351

7.  Time-trend of melanoma screening practice by primary care physicians: a meta-regression analysis.

Authors:  Antonis Valachis; Davide Mauri; Vassiliki Karampoiki; Nikolaos P Polyzos; Ivan Cortinovis; Georgios Koukourakis; Georgios Zacharias; Apostolos Xilomenos; Maria Tsappi; Giovanni Casazza
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

8.  Estimating the economic costs of skin cancer in New South Wales, Australia.

Authors:  Christopher M Doran; Rod Ling; Joshua Byrnes; Melanie Crane; Andrew Searles; Donna Perez; Anthony Shakeshaft
Journal:  BMC Public Health       Date:  2015-09-23       Impact factor: 3.295

Review 9.  Melanoma biomolecules: independently identified but functionally intertwined.

Authors:  Danielle E Dye; Sandra Medic; Mel Ziman; Deirdre R Coombe
Journal:  Front Oncol       Date:  2013-09-24       Impact factor: 6.244

10.  Melanoma incidence and mortality in Scotland 1979-2003.

Authors:  R M MacKie; C Bray; J Vestey; V Doherty; A Evans; D Thomson; M Nicolson
Journal:  Br J Cancer       Date:  2007-05-29       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.